Key points from article :
One in three adults aged 60 and over suffering from a hip fracture and dies within one year.
Clinical trials are done for a new drug targeted to heal broken bones faster and strengthen weak bones.
Injectable drug concentrates at the fracture site while reducing exposure to the rest of the body.
Novosteo can be applied for dental implants, head, and facial fractures, and hip and knee replacements.
Novosteo was founded to reduce the morbidity, mortality, and loss of productivity associated with bone fractures.
